Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for primary prevention of cardiovascular disease in diabetic patients
TCTR20220804004Phase 2Active, not recruiting
- Sponsor
- Pakchongnana Hospital
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in cardiac morbidity, type 2 diabetes mellitus (T2DM), sponsored by Pakchongnana Hospital. Started Sep 2021; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
cardiac morbiditytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20220804004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220804004.